In the BioHarmony Drug Report Database
Methoxamine
Vasoxyl (methoxamine) is a small molecule pharmaceutical. Methoxamine was first approved as Vasoxyl on 1982-01-01. The pharmaceutical is active against alpha-1A adrenergic receptor. In addition, it is known to target alpha-1D adrenergic receptor and alpha-1B adrenergic receptor.
Trade Name
|
Vasoxyl |
|---|---|
Common Name
|
methoxamine |
ChEMBL ID
|
CHEMBL524 |
Indication
|
|
Drug Class
|
Image (chem structure or protein)